MPX Bioceutical Corporation, formerly known as the Canadian Bioceutical Corporation, is a multi-state diversified cannabis company with operations focused in the U.S. in the adult use and medical cannabis markets. The company’s foundation is built on its profitable operations in Arizona, with two Health 4 Life Dispensaries and well established Melting Point Extracts (MPX) Brand; it also has operations in Massachusetts. MPX Bioceutical Corporation recently completed its agreement to acquire GreenMart operations in Nevada and has signed non-binding letters of intent to purchase dispensary and production licenses in Maryland. MPX Bioceutical Corporation plans to replicate its success in Arizona to become a dominant multi-state operator.
We’re replicating profitable operations and well-established brands to build a multi-state presence
Most MPX Bioceutical Corporation’s operations are U.S.-based, but we have also applied for a license in Canada
Established brands like MPX, Health4Life, and Salus BioPharma meet the needs of adult recreational and medical cannabis users
MPX Bioceutical Corporation signed a definitive agreement to create a joint venture with Panaxia to develop proprietary, smokeless pharma-grade products using cannabis
Committed to consistent best-in-class quality
MPX Bioceutical Corporation Delivers
Profitable operations and a healthy balance sheet provides financial flexibility
From seed to sale, MPX Bioceutical Corporation controls quality ensuring consistent quality
Established brands capture both adult recreational and medical market share
Senior executives with strong track records focused on flawless execution
Canadian Bioceutical Teams Up with Israeli-based Panaxia
Canadian Bioceutical has teamed up with Panaxia to develop, market and sell pharma-grade cannabis products.